ประกวดราคาซื้อยา Teriparatide inj ๗๕๐ mcg/๓ ml

This project aims to procure Teriparatide 750 mcg/3 ml solution for injection in a 3 ml prefilled pen format, which is a sterile, clear, and colorless solution for subcutaneous injection containing Teriparatide 250 mcg/ml. Bidders must offer products packaged in sterile, ready-to-inject containers with light-protective packaging and clearly labeled with details such as the drug name, key ingredients, strength, manufacturing date, expiration date, lot number, and registration number, as well as warnings for storage at 2-8 degrees Celsius and a “Do not freeze” warning.

The selection of proposals will be based on the lowest price from bidders whose Teriparatide specifications meet the requirements. Bidders must submit documents such as drug registration permits, drug manufacturing standard certifications, drug quality documents, and drug samples for consideration. Additionally, the government reserves the right not to consider drug products that have a history of recalls by the FDA within one year prior to the date of the electronic bidding announcement.